Scientific Research News

HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics presents EACR 2026 data linking ribosome stress biology to small RNA biomarkers in lung cancer....

LONDON--(BUSINESS WIRE)--IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, has successfully brought its Series A to over $53 million (£40 million) in an oversubscribed financing round, co-led by IQ Capital and Molten Ventures, and supported by The British Business Bank and Meltwind alongside existing investors. IMU has built the world’s largest immune dataset, scaling to more...

DUBLIN--(BUSINESS WIRE)--Primecore, the international life sciences and advanced technology program management company, accelerates international growth plans....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation radiopharmaceuticals for the treatment of cancer, today announced interim data from Part 3 of its Phase 2 CONVERGE-01 study of Ac-225 rosopatamab tetraxetan (CONV01-α) in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with Lu-177-PSMA radioligand therapy (Lu-PSMA). In the study, CONV01-α demonstrated promising anti-tumor act...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in the following investor conferences in June: Goldman Sachs 47th Annual Global Healthcare Conference Fireside chat: Monday, June 8, at 10:40 a.m. ET at the Loews Miami Beach Hotel in Miami Beach, Fla. Oppenheimer CNS and Neuro-Muscular Summit Investor meetings: Wednesday, June 10, 2026 at The Bath Club i...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to thirteen newly hired non-executive employees consisting of options to purchase an aggregate of 462,190 common shares of the Company (the "Options") with effective grant dates of May 18, 2...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of twelve research grants to universities under the company’s fifteenth Annual Research Award Program. “Research and clinical evidence continue to be at the core of...

NEW YORK--(BUSINESS WIRE)--Waypoint Bio, an AI-native biotech company using spatial biology to design next-generation CAR T therapies for solid tumors, announced today that it closed a $20M Series A financing round. The financing was led by Amplify Partners and Elliot Hershberg will join the board of directors. General Catalyst, Time BioVentures, Mitsui Global Investments, and Lux Capital participated in the round, alongside existing investors including Hummingbird Ventures. The Series A will f...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--SCIEX launches the novus V55 system with SCIEX OS 5.0 software and AI enablement tools....

MARLBOROUGH, Mass.--(BUSINESS WIRE)--SCIEX advances the ZenoTOF line with platform-wide expansions in software, integrations, and key collaborations...